Miscellaneous

 Home InvestorsInvestor Information Miscellaneous

Select

  • Buyback-2020
  • Buyback-2019
  • Scheme of Arrangement
  • SEBI Observation letter

  • Memorandum and Articles of Association

  • Opinion on Taxation

  • Maximum Permissible Limit Certificate

  • Firm Arrangement Certificate

  • Escrow Agreement

  • Annual Report 2019-2020

  • Annual Report 2018-2019

  • Annual Report 2017-2018

  • Affidavit Declaration of Solvency

  • Ajanta Pharma Limited - Advertisement

  • Letter of Offer

  • Tender Form - Physical

  • Tender Form - Demat

  • Form SH-4

  • Draft Letter of Offer

  • Public Announcement

  • Board Resolution for Buyback

  • Outcome of Board meeting regarding buyback

  • Intimation of Buy Back of Shares

  • Tender Form - Physical

  • Tender Form - Demat

  • Letter of Offer

  • Form SH-4

  • Draft Letter of Offer

  • Public Announcement

  • Record Date Intimation

  • Outcome of Board meeting regarding buyback

  • Intimation of Buy Back of Shares

  • Voting Results & Scrutinizers report

  • Revised Valuation report

  • Reply to BSE w.r.t. Pricing

  • NSE Observation Letter

  • BSE Observation Letter

  • Complaint Report

  • Valuation Report

  • Statement of Audited Financials of APL & GIPL

  • Report of Audit Committee

  • Rationale of the merger

  • Quarterly Compliance Report

  • Pre & post amalgamation Networth certificate

  • Pre & post shareholding pattern of APL

  • NSE Covering Letter

  • Fairness opinion from Merchant Banker

  • Draft Scheme of Amalgamation & Arrangement

  • Confirmation by CS to NSE in the prescribed format

  • Confirmation by CS to BSE in the prescribed format

  • Confirmation by CS for non-default

  • Compliance Report

  • Certified copy of Board Resolution APL & GIPL

  • Certificate from Statutory Auditor on accounting treatment

  • Capital evolution of APL & GIPL

  • BSE Covering letter

  • Brief details of Transferor & transferee

  • Annual Report of APL & GIPL

Scroll